Laurus Labs informs about updates on acquisition

17 Feb 2024 Evaluate
With reference to disclosures dated May 31, 2023 and July 12, 2023 regarding the signing of definitive agreements to acquire additional stake of 7.24% (on fully diluted basis) in Immunoadoptive Cell Therapy Private Limited (lmmunoACT), an advanced cell and gene therapy company for a cash consideration of Rs 80 Crores and update on payment of Tranche1 subscription amount to ImmunoACT respectively, Laurus Labs has informed that the Company has paid the subscription amount of Rs 32,00,75,184 (Rupees Thirty Two Crores Seventy Five Thousand One Hundred and Eighty Four only) as ‘Tranche 2 (Final) Subscription Amount’. The Shareholding of the Company in ImmunoACT is 33.86% (on a fully-diluted basis).

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

570.80 3.65 (0.64%)
26-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.50
Dr. Reddys Lab 1355.15
Cipla 1489.20
Lupin 2181.60
Zydus Lifesciences 959.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.